Andrew Calciano, MD
NPI 1942201702 · Dermatology Physician · Santa Cruz, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1942201702
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- G66560 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
15,421 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 6,591 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,851 | $102 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 1,620 | $62 |
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 | 1,351 | $40 |
| Application of Ultraviolet Light to Skin96900 | 489 | $31 |
| Biopsy of Related Skin Growth, First Growth11102 | 487 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 27 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 219 | 103 |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 158 | 87 |
| Triamcinolone Acetonide | 146 | 97 |
| Hydrocortisone | 102 | 72 |
| Cephalexin | 66 | 59 |
| Metronidazole | 65 | 37 |
| Mupirocin | 48 | 43 |
| Fluorouracil | 45 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$146 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 1661 Soquel Dr Ste CSanta Cruz, CA 95065-1709Phone: (831) 476-2444Fax: (831) 476-0705
- 1661 Soquel Dr Ste BSanta Cruz, CA 95065-1709Phone: (831) 476-2444Fax: (831) 476-0705
Registry dates
- Enumerated
- 2005-08-02
- Last updated
- 2024-01-19
- Certified
- 2024-01-19
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.